Deutsche Bank’s Korro Bio KRRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$144K Sell
14,541
-1,407
-9% -$17.3K ﹤0.01% 3250
2026
Q2
$210K Buy
15,948
+5,404
+51% +$67.1K ﹤0.01% 3228
2026
Q1
$119K Sell
10,544
-2,214
-17% -$24.4K ﹤0.01% 3201
2025
Q4
$102K Buy
12,758
+9,027
+242% +$211K ﹤0.01% 3285
2025
Q3
$179K Buy
3,731
+115
+3% +$2.55K ﹤0.01% 3115
2025
Q2
$45.2K Hold
3,616
– – ﹤0.01% 3422
2025
Q1
$63K Sell
3,616
-494
-12% -$14.6K ﹤0.01% 3331
2024
Q4
$156K Buy
4,110
+935
+29% +$48K ﹤0.01% 3165
2024
Q3
$106K Buy
+3,175
New +$134K ﹤0.01% 3202
2022
Q2
– Sell
-347
Closed -$37K – 4231
2022
Q1
$37K Sell
347
-41
-11% -$7.83K ﹤0.01% 3926
2021
Q4
$100K Sell
388
-82
-17% -$24.9K ﹤0.01% 3703
2021
Q3
$166K Sell
470
-35
-7% -$13.8K ﹤0.01% 3664
2021
Q2
$252K Buy
505
+132
+35% +$64.5K ﹤0.01% 3651
2021
Q1
$177K Sell
373
-53
-12% -$103K ﹤0.01% 3702
2020
Q4
$750K Buy
426
+148
+53% +$195K ﹤0.01% 2644
2020
Q3
$267K Sell
278
-7
-2% -$7.51K ﹤0.01% 3047
2020
Q2
$332K Buy
285
+244
+595% +$220K ﹤0.01% 2853
2020
Q1
$37K Buy
41
+2
+5% +$2.16K ﹤0.01% 3676
2019
Q4
$33K Buy
+39
New +$30.3K ﹤0.01% 4125

Other funds holding KRRO

Deutsche Bank's KRRO Position: Q3 2026 in Review

Deutsche Bank reduced its Korro Bio (KRRO) stake by 8.8% in Q3 2026, selling an estimated $17.3K and leaving 14,541 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #3250.

Deutsche Bank first reported a position in KRRO in Q4 2019 and has held it in 19 quarters since. The position peaked at $750K in Q4 2020. 40 funds tracked by Wall St. Rank hold KRRO as of Q3 2026.

  • Deutsche Bank held 14,541 shares of Korro Bio worth $144K as of Q3 2026.
  • Deutsche Bank sold 1,407 Korro Bio shares in Q3 2026, an estimated $17.3K.
  • Korro Bio made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #3250 holding.
  • Deutsche Bank first reported a position in Korro Bio in Q4 2019 and has held it in 19 quarters since.
  • Deutsche Bank's Korro Bio position peaked at $750K in Q4 2020.
  • 40 funds tracked by Wall St. Rank held Korro Bio as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.